WHO ICTRP trial

Clinical study of human umbilical cord mesenchymal stem cells (HUC-MSCs) on…

ChiCTR2000040778 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting

Key facts

Trial ID ChiCTR2000040778
Public title Clinical study of human umbilical cord mesenchymal stem cells (HUC-MSCs) on heart failure with reduced ejection fraction (HFrEF)
Scientific title Clinical study of human umbilical cord mesenchymal stem cells (HUC-MSCs) on heart failure with reduced ejection fraction (HFrEF)
Primary sponsor Shanghai Oriental Hospital
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Recruiting
Study type Interventional study
Phase 1-2
Countries China
Conditions heart failure with reduced ejection fraction
Interventions control:Common drug therapy;HUC-MSCs therapy:common durg and HUM-MSCs iv injection;HUC-MSCs and chinese medicine therapy:common durg, HUM-MSCs iv injection and classic chinese medicine combined thearpy;chinese medicine therapy:common durg…
Registration date Dec 10, 2020
Target size control:20;HUC-MSCs therapy:20;HUC-MSCs and chinese medicine therapy:20;chinese…
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations